Skip to main content

Advertisement

Log in

Antiviral Activity of Rosmarinic Acid Against Four Serotypes of Dengue Virus

  • Short Communication
  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

The present study was undertaken to evaluate the putative antiviral activity of Rosmarinic acid (RA) against four serotypes of dengue virus (DENV). Our previous in silico binding analysis revealed that RA binds strongly to the envelope domain III (EDIII) protein of all four DENV serotypes. We employed an in vitro Biolayer Interferometry-based OCTET™ platform to study the binding interaction of RA with EDIII protein of the four DENV serotypes. Additionally, a functional plaque assay was developed to investigate the potential inhibition of infection of the four DENV serotypes. Using OCTET™, the binding interaction of RA to DENV-EDIII protein of the four DENV serotypes demonstrates interaction which can be arranged in the following order: EDIII-DENV1 (Koff value of 1.05 s−1) > EDIII-DENV2 (Koff value of 5.63 × 10–01 s−1) > EDIII-DENV3 (Koff value of 4.63 × 10–02 s−1) > EDIII-DENV4 (Koff value of 3.53 × 10–02 s−1). Subsequently, the inhibiting ability of RA using plaque assay confirmed reduction in the number of plaques for all four serotypes, indicating the ability of RA not only to bind, but also to inhibit the infection of four serotypes in cell culture, while being non-toxic at the concentrations used in the study. However, the effect of RA was variable on different serotypes, demonstrating highest effect on DENV1 (EC50 = 13.73 µg/mL, SI ≥ 728) followed by DENV2 (EC50 = 77.74 µg/mL, SI  ≥ 129), DENV3 (EC50 = 244 µg/mL, SI ≥ 41) and DENV4 (EC50 = 280 µg/mL, SI ≥ 36).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Data Availability

Yes.

Code Availability

NA.

References

  1. Carlos Castaño-Osorio J, María Giraldo-Garcia A, Isabel Giraldo M (2019) Current status of vaccines against dengue virus. In: Dengue fever - a resilient threat in the face of innovation

  2. Liu Y, Liu J, Cheng G (2016) Vaccines and immunization strategies for dengue prevention. Emerg Microbes Infect 5:e77

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Ghosh A, Dar L (2015) Dengue vaccines: challenges, development, current status and prospects. Indian J Med Microbiol 33:3–15

    Article  CAS  Google Scholar 

  4. Dejnirattisai W, Jumnainsong A, Onsirisakul N et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science (80-) 328:745–748. https://doi.org/10.1126/science.1185181

    Article  CAS  Google Scholar 

  5. Morrone SR, Lok SM (2019) Structural perspectives of antibody-dependent enhancement of infection of dengue virus. Curr Opin Virol 36:1–8

    Article  CAS  Google Scholar 

  6. Halstead SB (2015) Dengue antibody-dependent enhancement: knowns and unknowns. Antibodies Infect Dis. https://doi.org/10.1128/microbiolspec.aid-0022-2014

    Article  Google Scholar 

  7. Saxena SK, Saxena S, Saxena R et al (2010) Emerging trends, challenges and prospects in antiviral therapeutics and drug development for infectious diseases. Electron J Biol 6:26–31

    Google Scholar 

  8. Shiraki K, Daikoku T, Takemoto M et al (2012) Mechanism of action of antiviral drugs. Nihon Rinsho 70:545–551

    PubMed  Google Scholar 

  9. Yacoub S, Mongkolsapaya J, Screaton G (2013) The pathogenesis of dengue. Curr Opin Infect Dis 26:284–289

    Article  CAS  Google Scholar 

  10. Zhang X, Jia R, Shen H et al (2017) Structures and functions of the envelope glycoprotein in flavivirus infections. Viruses 9:1–14. https://doi.org/10.3390/v9110338

    Article  CAS  Google Scholar 

  11. Naithani R, Huma L, Holland L et al (2008) Antiviral activity of phytochemicals: a comprehensive review: mini-reviews. Med Chem 8:1106–1133. https://doi.org/10.2174/138955708785909943

    Article  CAS  Google Scholar 

  12. Moreno S, Scheyer T, Romano CS, Vojnov AA (2006) Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic Res 40:223–231. https://doi.org/10.1080/10715760500473834

    Article  CAS  PubMed  Google Scholar 

  13. Astani A, Reichling J, Schnitzler P (2012) Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy 58:70–77. https://doi.org/10.1159/000335590

    Article  CAS  PubMed  Google Scholar 

  14. Swarup V, Ghosh J, Ghosh S et al (2007) Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother 51:3367–3370. https://doi.org/10.1128/AAC.00041-07

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Panchal R, Bapat S, Mukherjee SCA (2021) In silico binding analysis of lutein and rosmarinic acid against envelope domain III protein of dengue virus. Indian J Pharmacol 53(53):471–479. https://doi.org/10.4103/ijp.IJP

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hernández-Hernández E, Ponce-Alquicira E, Jaramillo-Flores ME, Guerrero Legarreta I (2009) Antioxidant effect rosemary (Rosmarinus officinalis L.) and oregano (Origanum vulgare L.) extracts on TBARS and colour of model raw pork batters. Meat Sci 81:410–417. https://doi.org/10.1016/j.meatsci.2008.09.004

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Authors are grateful to Dr. Rajeev Dhere, Executive Director, Serum Institute of India, for generously facilitating with critical consumables and infrastructural facilities.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or non-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

RP designed and performed the binding kinetics and plaque experiment; SG* designed and performed the binding kinetics experiment; RP and SG* prepared the manuscript; RM developed the method for plaque assay; JR and SG provided technical expertise on the BLI assay; SM and AC reviewed the data and provided inputs in manuscript preparation. RP and AC had conceptualized the hypothesis. (SG*—Saikat Ghosh).

Corresponding authors

Correspondence to Ritesh Panchal or Abhay Chowdhary.

Ethics declarations

Conflict of interest:

No conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panchal, R., Ghosh, S., Mehla, R. et al. Antiviral Activity of Rosmarinic Acid Against Four Serotypes of Dengue Virus. Curr Microbiol 79, 203 (2022). https://doi.org/10.1007/s00284-022-02889-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00284-022-02889-3

Navigation